BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10175611)

  • 1. Dialysis modality selection among patients attending freestanding dialysis facilities.
    Kendix M
    Health Care Financ Rev; 1997; 18(4):3-21. PubMed ID: 10175611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of home dialysis by freestanding renal dialysis facilities.
    Kendix M
    Health Care Financ Rev; 1995; 17(2):105-22. PubMed ID: 10157371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-mix and treatment in end-stage renal disease: hemodialysis v peritoneal dialysis.
    Radecki SE; Mendenhall RC; Nissenson AR; Freeman RB; Blagg CR; Capelli JP; Gentile DE; Feinstein EI
    Am J Kidney Dis; 1988 Jan; 11(1):7-14. PubMed ID: 3122560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home dialysis and dialysis treatment modalities in the VA system.
    Wiegmann TB; Blumenkrantz M; Layard M; Schmidt RW; Shen F; Stead W
    Am J Kidney Dis; 1983 Jul; 3(1):32-6. PubMed ID: 6346865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching and the definition of modality in end-stage renal disease treatment.
    Smith DG; Wheeler JR
    Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment modality patterns and transplantation among the United States pediatric end-stage renal disease population: a longitudinal study.
    Held PJ; Turenne MN; Liska DW; Zobel DL; Webb RL; Alexander SR; Jones C
    Clin Transpl; 1991; ():71-85. PubMed ID: 1820148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality risks of peritoneal dialysis and hemodialysis.
    Collins AJ; Hao W; Xia H; Ebben JP; Everson SE; Constantini EG; Ma JZ
    Am J Kidney Dis; 1999 Dec; 34(6):1065-74. PubMed ID: 10585316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
    Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantity and quality of ESRD treatment in the United States of America.
    Sadler J
    Contrib Nephrol; 1990; 78():181-5. PubMed ID: 2225835
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease.
    Thaweethamcharoen T; Sritippayawan S; Noparatayaporn P; Aiyasanon N
    Value Health Reg Issues; 2020 May; 21():181-187. PubMed ID: 32044691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies.
    Shukla AM; Bozorgmehri S; Ruchi R; Mohandas R; Hale-Gallardo JL; Ozrazgat-Baslanti T; Orozco T; Segal MS; Jia H
    Perit Dial Int; 2021 Sep; 41(5):453-462. PubMed ID: 33258420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis facility and patient characteristics associated with utilization of home dialysis.
    Walker DR; Inglese GW; Sloand JA; Just PM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1649-54. PubMed ID: 20634324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in choice of dialysis modality for children with end-stage renal disease.
    Furth SL; Powe NR; Hwang W; Neu AM; Fivush BA
    Pediatrics; 1997 Apr; 99(4):E6. PubMed ID: 9099781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
    Dor A; Held PJ; Pauly MV
    Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rehabilitation in patients undergoing home dialysis. Continuous ambulatory or cyclic peritoneal dialysis vs home hemodialysis.
    Rubin J; Case G; Bower J
    Arch Intern Med; 1990 Jul; 150(7):1429-31. PubMed ID: 2369241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facility Practice Variation to Help Understand the Effects of Public Policy: Insights from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Fuller DS; Robinson BM
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):190-199. PubMed ID: 28062678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis therapy among elderly patients; data from the Canadian Organ Replacement Register, 1981-1991.
    Fenton SS; Desmeules M; Jeffery JR; Corman JL
    Adv Perit Dial; 1993; 9():124-9. PubMed ID: 8105905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.